Thermo Fisher Scientific Inc. (TMO)
BMV
10,350.00
-382.00 (-3.56%)
Closed
Aug 24, 2026
Day's Range
10,350.0010,350.00
52 wk Range
7,599.0111,280.00
Financial Statements - TMO - Thermo Fisher Scientific Inc.
Revenue
44.55B▼ 94.0%
Net Income
6.72B▼ 93.8%Net Margin 15.1%
EBITDA
11.85B▼ 94.2%
Free Cash Flow
6.29B▼ 95.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 44.55B | 736.49B | 42.85B | 44.91B | 39.21B | 32.21B |
| Cost of Goods | 26.31B | 432.44B | 25.75B | 25.94B | 19.57B | 16.21B |
| Gross Profit | 18.23B | 304.05B | 17.10B | 18.97B | 19.63B | 16B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 8.11B | 132.54B | 7.31B | 8.50B | 10.22B | 7.89B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -374M | -6.30B | -524M | -218M | -891M | -175M |
| Pre Tax Income | 7.30B | 120.86B | 6.29B | 7.83B | 8.84B | 7.23B |
| Income Tax | 547M | 11.28B | 284M | 703M | 1.10B | 850M |
| Net Income | 6.72B | 108.86B | 5.95B | 6.96B | 7.72B | 6.37B |
| EPS Basic | 17.77 | 16.58 | 15.52 | 17.75 | 19.62 | 16.09 |
| EPS Diluted | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 | 15.96 |
| Basic Shares Outstanding | 377M | 6.56B | 18.99M | 19.19M | 19.29M | 19.39M |
| Diluted Shares Outstanding | 377M | 6.56B | 18.99M | 19.19M | 19.29M | 19.39M |
| Ebit | 8.72B | 144.74B | 7.67B | 8.56B | 9.37B | 7.78B |
| Ebitda | 11.85B | 204.27B | 11.53B | 12.05B | 12.16B | 10.20B |
| Net Income Continuous Operations | 6.72B | 108.86B | 5.95B | 6.96B | 7.72B | 6.37B |
| Minority Interests | -17M | -3M | 40M | -10M | -3M | -2M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
